Balance Sheet Protagonist Therapeutics, Inc.

Equities

PTGX

US74366E1029

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:00:00 2026-05-11 EDT			5-day change	1st Jan Change
103.50 ^USD	+4.17%		+4.00%	+18.50%

04:24am	Protagonist Therapeutics Insider Sold Shares Worth $5,918,880, According to a Recent SEC Filing	MT
05-06	Wedbush Adjusts Price Target on Protagonist Therapeutics to $118 From $112, Maintains Outperform Rating	MT

95066b6264e08b0ab245.U4-QDzh2sKHtW2y6cbpTAMc6MFnbxWNfCa12nxR1Shc.Zsj6OVoY8dWrEhiNNok0cPFZSWmunSImU-Ip7FgeH1gb6shKShyC5KAyWA

Published financial data: PROTAGONIST THERAPEUTICS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	27.36M	26.58M	60M	434M	46.02M
Total Revenues	27.36M	26.58M	60M	434M	46.02M
Gross Profit	27.36M	26.58M	60M	434M	46.02M
Selling General & Admin Expenses, Total	27.2M	31.74M	33.49M	43.46M	44.85M
R&D Expenses	126M	126M	120M	138M	159M
Other Operating Expenses, Total	153M	158M	154M	182M	204M
Operating Income	-126M	-131M	-93.65M	253M	-158M
Interest Expense, Total	-	-	-	-	-
Interest And Investment Income	443K	4.06M	14.9M	26.32M	28.79M
Net Interest Expenses	443K	4.06M	14.9M	26.32M	28.79M
Currency Exchange Gains (Loss)	-149K	-80K	-201K	250K	-
Other Non Operating Income (Expenses)	-	-	-	-	27K
EBT, Excl. Unusual Items	-126M	-127M	-78.96M	279M	-129M
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	-126M	-127M	-78.96M	279M	-129M
Income Tax Expense	-	-	-	4.22M	838K
Earnings From Continuing Operations	-126M	-127M	-78.96M	275M	-130M
Net Income to Company	-126M	-127M	-78.96M	275M	-130M
Net Income - (IS)	-126M	-127M	-78.96M	275M	-130M
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	-126M	-127M	-78.96M	275M	-130M
Net Income to Common Excl. Extra Items	-126M	-127M	-78.96M	275M	-130M
Per Share Items
Net EPS - Basic	-2.71	-2.6	-1.39	4.47	-2.05
Basic EPS - Continuing Operations	-2.71	-2.6	-1.39	4.47	-2.05
Basic Weighted Average Shares Outstanding	46.32M	49.04M	56.76M	61.57M	63.57M
Net EPS - Diluted	-2.71	-2.6	-1.39	4.23	-2.05
Diluted EPS - Continuing Operations	-2.71	-2.6	-1.39	4.23	-2.05
Diluted Weighted Average Shares Outstanding	46.32M	49.04M	56.76M	65.08M	63.57M
Normalized Basic EPS	-1.69	-1.62	-0.87	2.84	-1.27
Normalized Diluted EPS	-1.69	-1.62	-0.87	2.68	-1.27
Supplemental Items
EBITDA	-125M	-130M	-92.68M	254M	-157M
EBITA	-126M	-131M	-93.65M	253M	-158M
EBIT	-126M	-131M	-93.65M	253M	-158M
EBITDAR	-123M	-128M	-90.48M	256M	-155M
Effective Tax Rate - (Ratio)	-	-	-	1.51	-0.65
Current Domestic Taxes	-	-	-	4.22M	838K
Current Foreign Taxes	-	-	-	-	-
Total Current Taxes	-	-	-	4.22M	838K
Deferred Foreign Taxes	-	-	-	-	-
Total Deferred Taxes	-	-	-	-	-
Normalized Net Income	-78.47M	-79.62M	-49.35M	175M	-80.82M
Interest on Long-Term Debt	-	-	-	-	-
Supplemental Operating Expense Items
General and Administrative Expenses	27.2M	31.74M	33.49M	43.46M	44.85M
Research And Development Expense From Footnotes	129M	126M	120M	138M	159M
Net Rental Expense, Total	1.87M	2.21M	2.2M	2.48M	2.31M
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Stock-Based Comp., R&D Exp. (Total)	9M	14.72M	17.06M	20.92M	26.42M
Stock-Based Comp., G&A Exp. (Total)	7.4M	9.48M	12.23M	16.64M	19.55M
Total Stock-Based Compensation	16.4M	24.2M	29.29M	37.55M	45.97M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	124M	126M	187M	97.25M	128M
Short Term Investments	203M	112M	155M	322M	439M
Total Cash And Short Term Investments	327M	237M	342M	419M	567M
Accounts Receivable, Total	1.57M	10K	10M	165M	121K
Other Receivables	3.77M	42K	332K	3.49M	4.38M
Total Receivables	5.33M	52K	10.33M	168M	4.5M
Prepaid Expenses	8.5M	5.67M	3.63M	4.24M	5.71M
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	341M	243M	356M	592M	578M
Gross Property Plant And Equipment	10.99M	9.88M	8.38M	19.64M	20M
Accumulated Depreciation	-4.26M	-5.25M	-6.23M	-7.04M	-8.32M
Net Property Plant And Equipment	6.73M	4.63M	2.15M	12.61M	11.69M
Long-term Investments	-	-	-	140M	78.64M
Deferred Tax Assets Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	225K	225K	225K	225K	287K
Total Assets	348M	248M	358M	745M	668M
Liabilities
Accounts Payable, Total	1.6M	3.64M	772K	1.62M	5.34M
Accrued Expenses, Total	37.31M	24.54M	19.26M	23.62M	28.08M
Current Portion of Leases	2.2M	2.52M	1.14M	510K	2.28M
Current Income Taxes Payable	-	-	-	2.69M	-
Unearned Revenue Current, Total	1.6M	-	-	18.89M	9.55M
Other Current Liabilities	1.31M	484K	102K	74K	185K
Total Current Liabilities	44.02M	31.18M	21.27M	47.4M	45.44M
Long-Term Debt	-	-	-	-	-
Long-Term Leases	3.66M	1.14M	-	10.36M	8.04M
Unearned Revenue Non Current	-	-	-	11.68M	-
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	47.67M	32.32M	21.27M	69.43M	53.48M
Common Stock, Total	-	-	1K	1K	1K
Additional Paid In Capital	710M	753M	952M	1.02B	1.08B
Retained Earnings	-409M	-537M	-616M	-341M	-471M
Comprehensive Income and Other	-299K	-359K	-105K	-82K	641K
Total Common Equity	300M	216M	337M	675M	615M
Total Equity	300M	216M	337M	675M	615M
Total Liabilities And Equity	348M	248M	358M	745M	668M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	48.41M	51.28M	58.27M	61.38M	63.81M
ECS Total Common Shares Outstanding	47.84M	49.34M	57.71M	61.04M	62.58M
Book Value / Share	6.27	4.37	5.83	11.06	9.82
Tangible Book Value	300M	216M	337M	675M	615M
Tangible Book Value Per Share	6.27	4.37	5.83	11.06	9.82
Total Debt	5.86M	3.66M	1.14M	10.87M	10.32M
Net Debt	-321M	-234M	-340M	-548M	-636M
Debt Equivalent Oper. Leases	14.97M	17.7M	17.58M	19.81M	18.46M
Account Code - Inventory Valuation	-	3	3	3	3
Machinery, Total	5.18M	5.91M	6.47M	7.8M	9.24M
Full Time Employees	118	105	112	126	132

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-126M	-127M	-78.96M	275M	-130M
Depreciation & Amortization - CF	2.78M	3.37M	3.31M	2.9M	1.28M
Depreciation & Amortization, Total	2.78M	3.37M	3.31M	2.9M	1.28M
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	1.83M	-549K	-4.57M	-8.88M	-7.22M
Stock-Based Compensation (CF)	16.4M	24.2M	29.29M	37.55M	45.97M
Other Operating Activities, Total	-121K	-	194K	-	1.58M
Change In Accounts Receivable	860K	1.56M	-9.99M	-155M	165M
Change In Accounts Payable	-1.39M	2.04M	-2.87M	842K	3.72M
Change in Unearned Revenues	-12.88M	-1.6M	-	30.57M	-21.02M
Change In Income Taxes	-	-	-	2.69M	-2.69M
Change in Other Net Operating Assets	10.21M	-9.77M	-6.65M	-1.71M	1.31M
Cash from Operations	-108M	-108M	-70.24M	184M	57.67M
Capital Expenditure	-1.1M	-795K	-609K	-1.36M	-1.59M
Sale of Property, Plant, and Equipment	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-14.76M	92.26M	-38.65M	-298M	-47.74M
Cash from Investing	-15.86M	91.47M	-39.26M	-299M	-49.33M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Long-Term Debt Repaid, Total	-	-	-	-	-
Total Debt Repaid	-	-	-	-	-
Issuance of Common Stock	130M	19M	171M	26.45M	23.34M
Repurchase of Common Stock	-189K	-188K	-769K	-600K	-479K
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-	25K	-	-	-
Cash from Financing	130M	18.84M	170M	25.85M	22.86M
Foreign Exchange Rate Adjustments	-126K	-90K	-	-	-
Net Change in Cash	6.07M	2.08M	60.98M	-89.48M	31.2M
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	-	-	-	1.53M	3.69M
Levered Free Cash Flow	-61.59M	-60.37M	-43.31M	65.11M	106M
Unlevered Free Cash Flow	-61.59M	-60.37M	-43.31M	65.11M	106M
Change In Net Working Capital	1M	5.04M	16.77M	132M	-159M
Net Debt Issued / Repaid	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-23.4	-27.57	-19.32	28.66	-13.99
Return on Total Capital	-26.6	-31.27	-21.01	30.87	-15.07
Return On Equity %	-43.32	-49.41	-28.59	54.39	-20.18
Return on Common Equity	-43.32	-49.41	-28.59	54.39	-20.18
Margin Analysis
Gross Profit Margin %	100	100	100	100	100
SG&A Margin	99.41	119.4	55.82	10	97.47
EBITDA Margin %	-457.04	-490.35	-154.46	58.39	-340.85
EBITA Margin %	-460.01	-494.24	-156.09	58.2	-343.63
EBIT Margin %	-460.01	-494.24	-156.09	58.2	-343.63
Income From Continuing Operations Margin %	-458.94	-479.26	-131.59	63.34	-282.83
Net Income Margin %	-458.94	-479.26	-131.59	63.34	-282.83
Net Avail. For Common Margin %	-458.94	-479.26	-131.59	63.34	-282.83
Normalized Net Income Margin	-286.83	-299.54	-82.24	40.2	-175.63
Levered Free Cash Flow Margin	-225.13	-227.12	-72.18	14.99	229.53
Unlevered Free Cash Flow Margin	-225.13	-227.12	-72.18	14.99	229.53
Asset Turnover
Asset Turnover	0.08	0.09	0.2	0.79	0.07
Fixed Assets Turnover	4.16	4.68	17.71	58.88	3.79
Receivables Turnover (Average Receivables)	13.71	33.73	11.99	4.96	0.56
Short Term Liquidity
Current Ratio	7.74	7.8	16.71	12.48	12.71
Quick Ratio	7.55	7.61	16.54	12.39	12.58
Operating Cash Flow to Current Liabilities	-2.45	-3.47	-3.3	3.89	1.27
Days Sales Outstanding (Average Receivables)	26.63	10.82	30.45	73.72	654.87
Long Term Solvency
Total Debt/Equity	1.95	1.7	0.34	1.61	1.68
Total Debt / Total Capital	1.92	1.67	0.34	1.58	1.65
LT Debt/Equity	1.22	0.53	-	1.53	1.31
Long-Term Debt / Total Capital	1.2	0.52	-	1.51	1.29
Total Liabilities / Total Assets	13.71	13.04	5.94	9.32	8
EBIT / Interest Expense	-	-	-	-	-
EBITDA / Interest Expense	-	-	-	-	-
(EBITDA - Capex) / Interest Expense	-	-	-	-	-
Total Debt / EBITDA	-0.05	-0.03	-0.01	0.04	-0.07
Net Debt / EBITDA	2.61	1.82	3.76	-2.14	4.11
Total Debt / (EBITDA - Capex)	-0.05	-0.03	-0.01	0.04	-0.07
Net Debt / (EBITDA - Capex)	2.58	1.81	3.74	-2.15	4.07
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-4.44	-2.84	125.73	624.06	-89.41
Gross Profit, 1 Yr. Growth %	-4.44	-2.84	125.73	624.06	-89.41
EBITDA, 1 Yr. Growth %	96.69	4.24	-28.9	-373.72	-161.83
EBITA, 1 Yr. Growth %	95.06	4.39	-28.71	-369.98	-162.54
EBIT, 1 Yr. Growth %	95.06	4.39	-28.71	-369.98	-162.54
Earnings From Cont. Operations, 1 Yr. Growth %	89.8	1.47	-38.02	-448.54	-147.29
Net Income, 1 Yr. Growth %	89.8	1.47	-38.02	-448.54	-147.29
Normalized Net Income, 1 Yr. Growth %	95.38	1.47	-38.02	-453.88	-146.28
Diluted EPS Before Extra, 1 Yr. Growth %	40.93	-4.07	-46.45	-404.11	-148.46
Accounts Receivable, 1 Yr. Growth %	-35.45	-99.36	99.9K	1.55K	-99.93
Net Property, Plant and Equip., 1 Yr. Growth %	5.02	-31.3	-53.55	486.64	-7.28
Total Assets, 1 Yr. Growth %	7.16	-28.69	44.38	108.05	-10.28
Tangible Book Value, 1 Yr. Growth %	7.3	-28.14	56.15	100.58	-8.97
Common Equity, 1 Yr. Growth %	7.3	-28.14	56.15	100.58	-8.97
Cash From Operations, 1 Yr. Growth %	48.81	0.25	-35.05	-362.19	-68.68
Capital Expenditures, 1 Yr. Growth %	133.76	-27.79	-23.4	122.5	17.34
Levered Free Cash Flow, 1 Yr. Growth %	163.02	-1.98	-28.27	-250.35	62.23
Unlevered Free Cash Flow, 1 Yr. Growth %	167.28	-1.98	-28.27	-250.35	62.23
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	988.25	-3.64	48.1	304.27	-12.43
Gross Profit, 2 Yr. CAGR %	988.25	-3.64	48.1	304.27	-12.43
EBITDA, 2 Yr. CAGR %	25.18	43.19	-13.91	39.51	30.09
EBITA, 2 Yr. CAGR %	25.02	42.7	-13.73	38.73	29.94
EBIT, 2 Yr. CAGR %	25.02	42.7	-13.73	38.73	29.94
Earnings From Cont. Operations, 2 Yr. CAGR %	27.54	38.77	-20.7	46.97	28.39
Net Income, 2 Yr. CAGR %	27.54	38.77	-20.7	46.97	28.39
Normalized Net Income, 2 Yr. CAGR %	26.97	40.8	-20.7	48.1	27.98
Diluted EPS Before Extra, 2 Yr. CAGR %	-4.65	16.27	-28.36	27.55	21.4
Accounts Receivable, 2 Yr. CAGR %	-51.85	-93.58	152.7	12.75K	-89
Net Property, Plant and Equip., 2 Yr. CAGR %	-6.62	-15.06	-43.51	65.08	133.22
Total Assets, 2 Yr. CAGR %	49.81	-12.59	1.46	73.31	36.63
Tangible Book Value, 2 Yr. CAGR %	93.7	-12.19	5.93	76.98	35.12
Common Equity, 2 Yr. CAGR %	93.7	-12.19	5.93	76.98	35.12
Cash From Operations, 2 Yr. CAGR %	61.17	22.14	-19.31	30.5	-9.39
Capital Expenditures, 2 Yr. CAGR %	6.7	29.92	-25.63	30.55	61.58
Levered Free Cash Flow, 2 Yr. CAGR %	30.48	60.57	-16.15	3.85	56.17
Unlevered Free Cash Flow, 2 Yr. CAGR %	30.68	61.86	-16.15	3.85	56.17
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-4	386.39	27.97	151.35	20.07
Gross Profit, 3 Yr. CAGR %	-4	386.39	27.97	151.35	20.07
EBITDA, 3 Yr. CAGR %	44.15	17.77	13.39	26.59	6.37
EBITA, 3 Yr. CAGR %	43.86	17.72	13.23	26.18	6.37
EBIT, 3 Yr. CAGR %	43.86	17.72	13.23	26.18	6.37
Earnings From Cont. Operations, 3 Yr. CAGR %	47.75	18.18	6.08	29.9	0.72
Net Income, 3 Yr. CAGR %	47.75	18.18	6.08	29.9	0.72
Normalized Net Income, 3 Yr. CAGR %	46.75	17.83	7.11	30.56	0.5
Diluted EPS Before Extra, 3 Yr. CAGR %	15.91	-4.45	-10.24	15.99	-7.62
Accounts Receivable, 3 Yr. CAGR %	-30.11	-88.6	60.34	372.31	129.58
Net Property, Plant and Equip., 3 Yr. CAGR %	98.5	-15.7	-30.54	23.25	36.2
Total Assets, 3 Yr. CAGR %	35.59	16.97	3.33	28.9	39.16
Tangible Book Value, 3 Yr. CAGR %	38.67	39.18	6.39	31.05	41.8
Common Equity, 3 Yr. CAGR %	38.67	39.18	6.39	31.05	41.8
Cash From Operations, 3 Yr. CAGR %	29.26	37.58	-1.04	19.52	-18.9
Capital Expenditures, 3 Yr. CAGR %	31.34	-6.32	8.94	7.16	25.99
Levered Free Cash Flow, 3 Yr. CAGR %	17.92	18.62	22.75	1.87	20.5
Unlevered Free Cash Flow, 3 Yr. CAGR %	17.92	18.73	23.41	1.87	20.5
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	5.79	14.17	351.71	9.96
Gross Profit, 5 Yr. CAGR %	-	5.79	14.17	351.71	9.96
EBITDA, 5 Yr. CAGR %	31.05	28.3	17.29	26.03	19.8
EBITA, 5 Yr. CAGR %	30.96	28.23	17.25	25.72	19.64
EBIT, 5 Yr. CAGR %	30.96	28.23	17.25	25.72	19.64
Earnings From Cont. Operations, 5 Yr. CAGR %	27.56	28.08	15.19	28.95	14.49
Net Income, 5 Yr. CAGR %	27.56	28.08	15.19	28.95	14.49
Normalized Net Income, 5 Yr. CAGR %	27.56	28.08	14.73	29.11	15.01
Diluted EPS Before Extra, 5 Yr. CAGR %	-14.13	4.48	-4.38	7.25	1.29
Accounts Receivable, 5 Yr. CAGR %	-	-64.67	16.87	89.48	-45.1
Net Property, Plant and Equip., 5 Yr. CAGR %	64.33	39.39	20.07	10.3	12.76
Total Assets, 5 Yr. CAGR %	29.9	8.65	20.74	36.89	15.54
Tangible Book Value, 5 Yr. CAGR %	27.93	12.32	24.51	53.22	17.06
Common Equity, 5 Yr. CAGR %	27.93	12.32	24.51	53.22	17.06
Cash From Operations, 5 Yr. CAGR %	29.19	94.63	7.06	34.7	-4.47
Capital Expenditures, 5 Yr. CAGR %	25.98	3.6	4.62	6.98	27.55
Levered Free Cash Flow, 5 Yr. CAGR %	27.37	31.91	2.89	12.47	35.16
Unlevered Free Cash Flow, 5 Yr. CAGR %	27.37	31.91	2.89	12.54	35.6